3.4. Clinical Study: Signaling Pathway Activity in CD4+ T Cells Derived from Blood, Lymph Nodes, and Breast Cancer Tissue Samples of Patients with Primary Breast Cancer. Here, CD4 is linked to breast carcinoma.